ライフサイエンスコーパス: glyceryl trinitrate

1 sting or reducing anginal episodes or use of glyceryl trinitrate.

2 ere was no significant change in response to glyceryl trinitrate.

3 onduit artery selectivity similar to that of glyceryl trinitrate (0.013-4.4 nmol/min) over resistance

4 achidonic acid: 0.2, 2, and 20 nmol/min; and glyceryl trinitrate 1, 2, and 4 pmol/min) were construct

5 f albuterol (5 microg/min, DeltaRI(ALB)) and glyceryl trinitrate (5 microg/min, DeltaRI(GTN)).

6 The metabolism of nitrovasodilators such as glyceryl trinitrate and nitroprusside provides the activ

7 P=0.045) after adjusting for the response to glyceryl trinitrate and was independent of conventional

8 , D-S-nitrosocysteine, S-nitrosoglutathione, glyceryl trinitrate, and sodium nitroprusside produced m

9 In addition, exogenous acetylcholine and glyceryl trinitrate both increase arterial distensibilit

10 ependent dilation, EDD) and after sublingual glyceryl trinitrate (causing endothelium-independent dil

11 There was no significant change in FMD or glyceryl trinitrate during the placebo phase.

12 .01% (P=0.036) with no change in response to glyceryl trinitrate (endothelial-independent dilatation)

13 ers of each sex, we assessed FMD response to glyceryl trinitrate (GTN) at baseline and at 8 hours and

14 donor drugs isosorbide mononitrate (ISMN) or glyceryl trinitrate (GTN) for stable angina.

15 Nitric oxide donors such as glyceryl trinitrate (GTN) have been shown to cause a rev

16 n each group, a migraine was induced using a glyceryl trinitrate (GTN) infusion.

17 Infusion of glyceryl trinitrate (GTN) into patients with migraine pr

18 Therefore, we investigated the effect of glyceryl trinitrate (GTN) on the efficacy of cell engraf

19 The NO donor glyceryl trinitrate (GTN) provokes delayed migraine atta

20 Albuterol (salbutamol) and glyceryl trinitrate (GTN) were administered locally by b

21 The effects of glyceryl trinitrate (GTN), amlodipine, and atenolol were

22 Using glyceryl trinitrate (GTN), an agonist of nitric oxide (N

23 ing pacing and after intragraft injection of glyceryl trinitrate (GTN).

24 h after infusing the NO donor nitroglycerin [glyceryl trinitrate (GTN)] to migraineurs.

25 ent) and response to 50 microg of sublingual glyceryl trinitrate (GTN, endothelium independent) were

26 abolism of the cornerstone nitrovasodilator, glyceryl trinitrate (GTN; 0.1-100 mg/kg), in the rat in

27 (BK) and the endothelium-independent dilator glyceryl-trinitrate (GTN).

28 mediated dilatation [FMD]) and -independent (glyceryl trinitrate [GTN]) changes in brachial artery ar

29 yl dinitrate and nitrite from nitroglycerin (glyceryl trinitrate [GTN]) within mitochondria, leading

30 ular mechanisms through which nitroglycerin (glyceryl trinitrate, GTN) elicits nitric oxide (NO)-base

31 atalyzes the bioactivation of nitroglycerin (glyceryl trinitrate, GTN) in blood vessels, resulting in

32 Nitroglycerin (glyceryl trinitrate, GTN), originally manufactured by Al

33 ry flow-mediated (endothelium-dependent) and glyceryl trinitrate-induced (endothelium-independent) di

34 In contrast, glyceryl trinitrate-induced dilatation was similar in th

35 15) and lower FMD percentage (P = 0.026) and glyceryl trinitrate-induced dilation (P = 0.012) than he

36 pattern was identical in migraineurs during glyceryl trinitrate-induced migraine attacks as well as

37 ix control subjects at rest and during acute glyceryl trinitrate-induced migraine attacks using posit

38 ins tight for dihydroergotamine during acute glyceryl trinitrate-induced migraine attacks.

39 We used glyceryl trinitrate (nitroglycerin) to trigger premonito

40 thysmography with acetylcholine, bradykinin, glyceryl trinitrate, norepinephrine, and l-NG-monomethyl

41 Sublingual administration of the NO donor glyceryl trinitrate normalized platelet VASP phosphoryla

42 harged on the same day with diclofenac, 0.2% glyceryl-trinitrate ointment, lactulose, a telephone num

43 rently available nitric oxide donors such as glyceryl trinitrate or isosorbide mononitrate could be u

44 educed responses to bradykinin (P=0.005) and glyceryl trinitrate (P=0.006).

45 been short-term; a new topical, easy-to-use glyceryl trinitrate preparation has been shown to improv

46 inistration of the nitric oxide (NO) mimetic glyceryl trinitrate prevented altered uteroplacental per

47 Infusion of acetylcholine and glyceryl trinitrate reduced PWV significantly, by 6+/-4%

48 In in vitro studies, glyceryl trinitrate, sodium nitroprusside, and 3'-morpho

49 ts, intravenous infusion of three NO donors, glyceryl trinitrate, sodium nitroprusside, or 3'-morphol

50 pothalamus, seen in the premonitory phase of glyceryl trinitrate-triggered migraine attacks can expla

51 Responses to sublingual glyceryl trinitrate were unchanged.